Mined Therapeutics, Inc. — Form D
Mined Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-27. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-27
- Form: D
- Accession: 0001884272-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 18
- Date of first sale: 2021-09-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-414680
Issuer
- Name: Mined Therapeutics, Inc.
- CIK: 0001884272
- Entity type: Corporation
- Jurisdiction: MASSACHUSETTS
- Incorporated: 2021
- Address: 245 FIRST STREET, CAMBRIDGE, MA, 02142
- Phone: 617-595-5769
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Alex Koglin | Director | Santa Fe, NM |
| Thomas Nickoloff | Director | Champaign, IL |
| ANDREW SANDFORD | Director | Cambridge, MA |
| David Seldin | Director | Boston, MA |
| ANDREW SANDFORD | Executive Officer | Cambridge, MA |
More